SCHEMBL9529690

SCHEMBL9529690

CCCOc1nc(CCC(C)C)n(Cc2ccc(-c3ccccc3-c3nnn[nH]3)cc2)n1

nearest known ligand 0.42

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
AGTR1 P30556 7/20 0.42
AGTR2 P50052 7/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9529701 0.93 AGTR1 (0.41) AGTR1AGTR2
SCHEMBL9531110 0.92 AGTR1 (0.45) AGTR1AGTR2
SCHEMBL9527874 0.91 AGTR1 (0.41) AGTR1AGTR2
SCHEMBL9528230 0.90 AGTR1 (0.52) AGTR1AGTR2
SCHEMBL9528071 0.90 AGTR1 (0.49) AGTR1AGTR2
SCHEMBL9529760 0.89 AGTR1 (0.41) AGTR1AGTR2
SCHEMBL9529351 0.89 AGTR1 (0.42) AGTR1AGTR2
SCHEMBL9527516 0.88 AGTR1 (0.53) AGTR1AGTR2
SCHEMBL9527522 0.87 AGTR1 (0.42) AGTR1AGTR2
SCHEMBL9528313 0.87 AGTR1 (0.42) AGTR1AGTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0527851-A1 1H-SUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1993-02-24 EP disclosed
US-5098920-A Hypotensive agents and treatment of congestive heart failure G. D. SEARLE & CO. (US) 1992-03-24 US disclosed
WO-1991017148-A1 1H-SUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1991-11-14 WO disclosed